BiotechTube

Inhaled Technosphere Insulin

Phase 2/3Recruiting
0 watching 0 views this week📈 Rising
60
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Diabetes, Gestational

Conditions

Diabetes, Gestational, Pregnancy Complications, Glucose Metabolism Disorders, Glucose Intolerance During Pregnancy

Trial Timeline

May 1, 2025 → Jul 1, 2025

NCT ID
NCT06535789

About Inhaled Technosphere Insulin

Inhaled Technosphere Insulin is a phase 2/3 stage product being developed by MannKind Corp for Diabetes, Gestational. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06535789. Target conditions include Diabetes, Gestational, Pregnancy Complications, Glucose Metabolism Disorders.

Hype Score Breakdown

Clinical
22
Activity
15
Company
5
Novelty
7
Community
8

Clinical Trials (1)

NCT IDPhaseStatus
NCT06535789Phase 2/3Recruiting

Competing Products

20 competing products in Diabetes, Gestational

See all competitors
ProductCompanyStageHype Score
add-on pioglitazone + add-on sulphonylureaAMD BiotechApproved
77
MKP10241 + PlaceboMankind PharmaPhase 2
52
Daily injection of KBP/placebo for up to 28 daysEli LillyPhase 1
33
LY3209590 + Insulin DegludecEli LillyPhase 1
33
AC2993Eli LillyPhase 3
77
LY3209590 + PlaceboEli LillyPhase 1
33
Insulin Lispro Protamine Suspension + Insulin GlargineEli LillyPhase 3
77
LY2963016 + LantusEli LillyPhase 1
33
Empagliflozin + Other SGLT2 inhibitors + Other non-insulin GLDsEli LillyPre-clinical
23
Insulin Lispro Mix25 + Insulin Lispro Mix50Eli LillyApproved
85
Nasal Glucagon + Intramuscular GlucagonEli LillyPhase 3
77
Retatrutide + PlaceboEli LillyPhase 1
33
AG019 - Low Dose + Teplizumab + Placebo-AG019 + Placebo-Teplizumab + AG019 - High Dose + AG019 - High DosePrecigenPhase 1/2
36
LY4057996 SC + LY4057996 IV + Placebo SC + Placebo IV + Degludec SC + Lispro SC + Degludec IV + Pre-study basal insulin SCEli LillyPhase 1
33
Placebo + LinagliptinEli LillyPhase 3
77
Insulin Glargine + Insulin Lispro Premix (mid-mixture and low-mixture)Eli LillyApproved
85
teplizumab or placeboEli LillyPhase 1
33
LY2428757 + PlaceboEli LillyPhase 2
52
Insulin Efsitora Alfa + Insulin DegludecEli LillyPhase 3
77
LY900014 (SC) + LY900014 (IV)Eli LillyPhase 1
33

Other Products from MannKind Corp

Afrezza plus One Drop | PremiumApproved
80
Technosphere insulinApproved
80
Afrezza + insulin degludec + Rapid-acting Insulin Analog + Basal InsulinApproved
80
Afrezza (insulin human) Inhalation Powder + insulin degludecApproved
80
Technosphere® Insulin with MedTone C Inhaler + Technosphere ®Insulin with Gen2 Inhaler + Insulin Aspart in combination with a basal insulinPhase 3
72